BCWorld Pharm Co. Ltd. - Product Pipeline Review - 2016

  • ID: 3876132
  • Company Profile
  • 33 pages
  • Global Markets Direct
1 of 4
BCWorld Pharm Co. Ltd. - Product Pipeline Review - 2016

Summary

‘BCWorld Pharm Co. Ltd. - Product Pipeline Review, 2016’, provides an overview of the BCWorld Pharm Co. Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by BCWorld Pharm Co. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of BCWorld Pharm Co. Ltd.
- The report provides overview of BCWorld Pharm Co. Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses BCWorld Pharm Co. Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features BCWorld Pharm Co. Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate BCWorld Pharm Co. Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for BCWorld Pharm Co. Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding BCWorld Pharm Co. Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

BCWorld Pharm Co. Ltd. Snapshot

BCWorld Pharm Co. Ltd. Overview

Key Information

Key Facts

BCWorld Pharm Co. Ltd. - Research and Development Overview

Key Therapeutic Areas

BCWorld Pharm Co. Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

BCWorld Pharm Co. Ltd. - Pipeline Products Glance

BCWorld Pharm Co. Ltd. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

BCWorld Pharm Co. Ltd. - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

BCWorld Pharm Co. Ltd. - Drug Profiles

BCWPA-001

Product Description

Mechanism of Action

R&D Progress

BCWPC-001

Product Description

Mechanism of Action

R&D Progress

risperidone SR

Product Description

Mechanism of Action

R&D Progress

BCWPD-003

Product Description

Mechanism of Action

R&D Progress

BCWPD-004

Product Description

Mechanism of Action

R&D Progress

BCWPP-001

Product Description

Mechanism of Action

R&D Progress

BCWPD-001

Product Description

Mechanism of Action

R&D Progress

BCWPD-006

Product Description

Mechanism of Action

R&D Progress

BCWPD-011

Product Description

Mechanism of Action

R&D Progress

BCWPE-003

Product Description

Mechanism of Action

R&D Progress

BCWPE-004

Product Description

Mechanism of Action

R&D Progress

BCWPY-001

Product Description

Mechanism of Action

R&D Progress

BCWPY-002

Product Description

Mechanism of Action

R&D Progress

BCWorld Pharm Co. Ltd. - Pipeline Analysis

BCWorld Pharm Co. Ltd. - Pipeline Products by Target

BCWorld Pharm Co. Ltd. - Pipeline Products by Route of Administration

BCWorld Pharm Co. Ltd. - Pipeline Products by Molecule Type

BCWorld Pharm Co. Ltd. - Pipeline Products by Mechanism of Action

BCWorld Pharm Co. Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

BCWorld Pharm Co. Ltd., Key Information

BCWorld Pharm Co. Ltd., Key Facts

BCWorld Pharm Co. Ltd. - Pipeline by Indication, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Stage of Development, 2016

BCWorld Pharm Co. Ltd. - Monotherapy Products in Pipeline, 2016

BCWorld Pharm Co. Ltd. - Phase I, 2016

BCWorld Pharm Co. Ltd. - IND/CTA Filed, 2016

BCWorld Pharm Co. Ltd. - Preclinical, 2016

BCWorld Pharm Co. Ltd. - Discovery, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Target, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Route of Administration, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Molecule Type, 2016

BCWorld Pharm Co. Ltd. - Pipeline Products by Mechanism of Action, 2016

BCWorld Pharm Co. Ltd., Other Locations 31List of Figures

BCWorld Pharm Co. Ltd. - Pipeline by Indication, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Stage of Development, 2016

BCWorld Pharm Co. Ltd. - Monotherapy Products in Pipeline, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Target, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Route of Administration, 2016

BCWorld Pharm Co. Ltd. - Pipeline by Molecule Type, 2016

BCWorld Pharm Co. Ltd. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll